Related Experiment Video

Updated: Aug 21, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Inactivating mutations of the Siah-1 gene in gastric cancer

Chang Jae Kim1, Yong Gu Cho, Cho Hyun Park

  • 1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Oncogene
|October 7, 2004
PubMed

Insights

Mutations in the Siah-1 gene may drive gastric cancer by stabilizing beta-catenin and blocking apoptosis. This study investigated Siah-1 gene alterations in gastric cancer patients, finding specific mutations linked to disease progression.

Area of Science:

  • Molecular biology
  • Oncology
  • Genetics

Background:

  • SIAH-1 (Drosophila seven in absentia homolog 1) is a p53-inducible gene.
  • Siah-1 regulates cell cycle arrest, tumor suppression, and apoptosis via beta-catenin degradation.
  • The role of Siah-1 genetic alterations in gastric cancer remains unclear.

Purpose of the Study:

  • To investigate genetic alterations of the Siah-1 gene in gastric cancer.
  • To determine the functional impact of Siah-1 mutations on beta-catenin regulation and apoptosis.

Main Methods:

  • Screening for Siah-1 gene mutations in 95 gastric cancer samples using single-strand conformational polymorphism and sequencing.
  • Transfection of HEK 293T cells with wild-type and mutant Siah-1.
  • Analysis of beta-catenin localization, cyclin D1 expression, and apoptosis induction.

Main Results:

  • Two missense mutations in the Siah-1 gene were identified in gastric cancer cases.
  • Siah-1 mutations were associated with nuclear translocation and cytoplasmic staining of beta-catenin.
  • Mutant Siah-1 stabilized cytoplasmic beta-catenin levels, even after adriamycin treatment.
  • Mutant Siah-1 failed to suppress cyclin D1 expression and induce apoptosis.

Conclusions:

  • Inactivating mutations of Siah-1 may contribute to gastric cancer development.
  • Siah-1 mutations promote gastric cancer by stabilizing beta-catenin and inhibiting apoptosis.

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...